4

OWNERSHIP DOCUMENT

Company: Inhibrx Biosciences, Inc.
Filed: May 30, 2024
Period of Report: May 30, 2024
Accession Number: 0000950142-24-001495

View Document ↗ View on SEC.gov ↗